Skip to Content

Kitabis Pak Approval History

FDA Approved: Yes (First approved December 2, 2014)
Brand name: Kitabis Pak
Generic name: tobramycin
Dosage form: Inhalation Solution
Company: PulmoFlow, Inc.
Treatment for: Cystic Fibrosis

Kitabis Pak (tobramycin) is an aminoglycoside inhalation solution co-packaged with a PARI LC PLUSĀ® Reusable Nebulizer for the management of cystic fibrosis.

Development History and FDA Approval Process for Kitabis Pak

DateArticle
Dec  3, 2014Approval FDA Approves PulmoFlow's Kitabis Pak Tobramycin & Nebulizer Combination for Cystic Fibrosis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide